Cargando…
Indian pharmaceutical patent prosecution: The changing role of Section 3(d)
India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of “secondary” pharmaceutical patents, i.e. patents on new forms of existing molecules and drugs. Previous research sug...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880378/ https://www.ncbi.nlm.nih.gov/pubmed/29608604 http://dx.doi.org/10.1371/journal.pone.0194714 |